V souladu s legislativou České republiky poskytuje Společnost služby pouze kvalifikovaným investorům!

Fusion Pharmaceuticals Incorporated (FUSN) Financial results for the second quarter of 2020

11.08.2020

Net loss - $18.91 per share, with consensus forecast - $0.49.
The company holds cash of $319 million.